CONDITIONS • WESTMINSTER, ARVADA, BROOMFIELD, THORTON & DENVER METRO
SIBO Treatment and Prevention in Westminster, CO
SIBO is one of the most common explanations for bloating, abdominal pain, and altered bowel habits that standard testing has repeatedly failed to find. It is also one of the most commonly missed diagnoses in gastroenterology.
Small intestinal bacterial overgrowth — SIBO — occurs when bacteria that normally live in the large intestine migrate into and overpopulate the small intestine. The small intestine is not designed to house large bacterial populations. When it does, the consequences reach far beyond the gut: systemic inflammation, nutrient malabsorption, pain amplification, hormonal disruption, and a wide range of symptoms that seem completely unrelated to digestion. SIBO is increasingly understood to be one of the root causes behind many IBS diagnoses, and it has a specific, testable mechanism with a specific, effective treatment when correctly identified.
Same-Day & Same-Week Appointments Available
WE UNDERSTAND WHAT YOU'RE GOING THROUGH
The bloating that appears within an hour of eating and makes you look and feel like a different person by mid-afternoon. The discomfort that has become so consistent you have stopped expecting meals to feel good.
SIBO has a particular quality that distinguishes it from ordinary digestive discomfort. The bloating is often rapid and severe — it can begin within thirty to ninety minutes of eating and progresses through the day regardless of how carefully you choose your food. The abdominal distension can be visible and physically uncomfortable. The gas and belching are embarrassing and seem entirely out of proportion to what you ate. Many SIBO patients learn to eat tiny amounts, eat only at home, or stop eating certain entire food categories in an attempt to control symptoms. The low-FODMAP diet helps somewhat. But the underlying bacterial problem remains, and the symptoms keep returning whenever the diet relaxes. What is rarely explained to these patients is that they are managing a bacterial overgrowth problem with dietary restriction alone — a strategy that addresses the food that feeds the bacteria without ever actually removing the bacteria. And beyond the gut, SIBO's systemic consequences are producing symptoms elsewhere in the body that no one has connected to the digestive picture.
WHAT YOU MAY BE EXPERIENCING
-
Significant bloating and abdominal distension, often within 60 to 90 minutes of eating
-
Excessive gas, belching, and flatulence that seems disproportionate to food intake
-
Abdominal pain or cramping that is often relieved by a bowel movement
-
Alternating diarrhea and constipation, or one dominant pattern
-
Symptoms clearly worse with high-carbohydrate or high-fiber foods and better on a low-FODMAP diet
-
Fatigue, brain fog, and joint pain alongside the gut symptoms
-
A diagnosis of IBS that has not fully responded to standard treatment
THE CONNECTION TO PAIN AND THE WHOLE BODY
SIBO is not just a digestive condition. The bacteria overgrowing in the small intestine produce inflammatory compounds that cross the gut lining and enter the bloodstream, driving systemic inflammation throughout the body. This systemic inflammation amplifies pain sensitivity, impairs tendon and joint recovery, disrupts hormonal signaling, and drives the fatigue and brain fog that SIBO patients experience.
If you have chronic musculoskeletal pain that is not responding as expected, SIBO-driven systemic inflammation may be one of the reasons why. Treating the SIBO reduces the whole-body inflammatory burden that standard pain treatment cannot resolve on its own.
WHAT YOU PROBABLY HAVEN'T BEEN TOLD
SIBO is present in an estimated 50 to 70 percent of people diagnosed with IBS. It is diagnosed with a simple breath test or stool analysis that standard gastroenterological workup almost never orders. The bacteria producing your symptoms can be specifically identified and specifically treated.
WHAT IS ACTUALLY HAPPENING IN SIBO — AND WHY THE SYMPTOMS GO SO FAR BEYOND THE GUT
The small intestine is responsible for most of the body's nutrient absorption. To do this effectively, it needs to have relatively few bacteria — the majority of the gut's bacterial population should reside in the large intestine, where they perform different functions and where the body's exposure to their metabolic byproducts is much more controlled. In SIBO, bacteria migrate from the large intestine into the small intestine and establish themselves there. When you eat carbohydrates or fermentable fibers, these bacteria ferment them before the small intestine has a chance to absorb them. The fermentation produces hydrogen gas, methane gas, or hydrogen sulfide gas depending on which bacterial species are dominant. These gases cause the bloating, pain, and altered bowel function. They also disrupt the local environment of the small intestine in ways that impair absorption of iron, B12, fat-soluble vitamins, and other nutrients.
Beyond gas production, SIBO bacteria produce lipopolysaccharides — inflammatory compounds from bacterial cell walls that cross the intestinal lining and enter the bloodstream when intestinal permeability is increased. This is the mechanism of SIBO's systemic reach. The lipopolysaccharides trigger the immune system, driving a chronic low-grade systemic inflammation that produces fatigue, brain fog, joint pain, skin conditions, and hormonal disruption far from the gut. For many patients, these systemic symptoms are more disabling than the digestive symptoms themselves — and they are rarely connected to their digestive picture.
The three types of SIBO — and why the type matters for treatment
Not all SIBO is the same. Hydrogen-dominant SIBO is the most common type, typically producing diarrhea-predominant symptoms and excessive gas. Methane-dominant SIBO — sometimes called intestinal methanogen overgrowth or IMO — tends to produce constipation, slower gut transit, and more severe bloating. Hydrogen sulfide SIBO is less commonly diagnosed but produces the characteristic sulfur or "rotten egg" quality to gas, as well as diarrhea and significant abdominal discomfort. The distinction matters because the treatment protocol — including both the antibiotic or herbal antimicrobial approach and the supportive protocols used alongside it — differs significantly between types. A breath test or stool analysis can identify which pattern is dominant and guides the treatment accordingly.
Treating hydrogen-dominant SIBO with protocols designed for methane-dominant disease, or vice versa, produces significantly worse outcomes. Type identification before treatment is not optional.
Why SIBO keeps coming back — and what standard treatment misses
SIBO recurrence rates are notoriously high after standard antibiotic treatment alone — studies suggest recurrence in 40 to 50 percent of patients within twelve months of an apparently successful course of rifaximin. The reason is that antibiotic treatment eliminates the bacteria but does not address the conditions that allowed the overgrowth to develop in the first place. The most important of these is impaired small intestinal motility: the small intestine has a housekeeping wave called the migrating motor complex that sweeps bacteria down toward the large intestine between meals. When this is sluggish or absent — from hypothyroidism, post-infectious nerve damage, prolonged PPI use, diabetes, or chronic stress — bacteria can re-establish themselves in the small intestine even after successful eradication. Addressing the motility defect is the most important recurrence prevention step available, and it is almost never part of standard SIBO management.
Prokinetic therapy — agents that stimulate the migrating motor complex between meals — is the most evidence-supported recurrence prevention strategy and is rarely prescribed after standard antibiotic SIBO treatment.
SIBO's systemic reach — conditions driven by the same bacterial overgrowth
SIBO has documented associations with conditions that appear completely unrelated to the gut. Rosacea is strongly associated with SIBO, and clearing the bacterial overgrowth produces skin improvement in many patients. Restless legs syndrome has been linked to iron malabsorption from SIBO. Fibromyalgia and chronic fatigue syndrome have high rates of concurrent SIBO. GERD is both a potential cause of SIBO (through impaired acid barrier function) and a consequence of it (through gas-driven pressure on the lower esophageal sphincter). Non-alcoholic fatty liver disease is associated with SIBO through increased intestinal permeability and lipopolysaccharide exposure. And chronic musculoskeletal pain conditions are amplified by the systemic inflammatory load SIBO generates. For patients presenting with any of these conditions alongside a digestive symptom pattern, SIBO testing should be among the first diagnostic steps — not the last resort after everything else has been tried.
The gut-brain-body connection in SIBO is one of the strongest arguments for treating digestive health as whole-body health rather than a separate specialty domain.
OUR APPROACH
Conventional care versus our approach
Standard SIBO treatment, when it is offered at all, consists of a course of rifaximin antibiotic with or without neomycin for methane-dominant cases, and limited follow-up. Our approach extends well beyond this: we test comprehensively, treat specifically, address the predisposing conditions that caused the overgrowth, and implement recurrence prevention as a primary component of the management plan from the beginning.
The conventional approach
What most patients experience
-
IBS label applied after structural disease ruled out; SIBO breath testing rarely ordered as part of the initial workup
-
Low-FODMAP diet recommended as primary management
-
If SIBO is suspected or confirmed, a course of rifaximin prescribed with or without neomycin
-
No follow-up breath test to confirm eradication; no recurrence prevention protocol
-
Predisposing conditions — hypothyroidism, motility impairment, PPI-related acid suppression, post-infectious nerve damage — rarely identified or addressed
-
Nutrient deficiencies from malabsorption, microbiome restoration, and intestinal permeability repair not addressed
The conventional approach to SIBO, when it is offered, treats the bacterial overgrowth in isolation without investigating the structural and functional conditions that caused it or implementing the strategies required to prevent its return.
What we do differently
-
Comprehensive SIBO stool analysis to identify the specific overgrowth type and guide the correct treatment protocol
-
Type-specific eradication: pharmaceutical antibiotics where indicated and coordinated with the patient's physician, or herbal antimicrobial protocols with comparable efficacy and lower recurrence rates in clinical studies
-
Investigation of predisposing conditions: thyroid function, gastric acid adequacy, PPI use and its effect on the upper digestive acid barrier, motility assessment, and history of prior gut infections or abdominal surgery
-
Prokinetic therapy after eradication to restore migrating motor complex function and prevent recolonization — the single most important recurrence prevention intervention and the one most consistently missing from standard care
-
Intestinal mucosal repair and microbiome restoration after eradication: L-glutamine, zinc carnosine, and specific probiotic protocols to rebuild gut integrity and prevent recolonization from the large intestine
-
Nutritional repletion for deficiencies produced by malabsorption during the SIBO period: iron, B12, fat-soluble vitamins, and magnesium — addressing the systemic consequences of the overgrowth, not just the overgrowth itself
We work with the patient's gastroenterologist where one is involved. Our role is the comprehensive SIBO evaluation and management that functional medicine brings — testing, treatment, predisposing condition management, recurrence prevention, and systemic consequence repair.
WHAT MAKES OUR APPROACH DIFFERENT — IN A SINGLE PARAGRAPH
Standard SIBO care treats the bacteria with antibiotics and sends the patient home. Our approach tests first to identify the specific overgrowth type, treats with the appropriate protocol for that type, and then immediately focuses on the two things that determine whether SIBO resolution lasts: addressing the predisposing condition that allowed the overgrowth to establish in the first place, and implementing prokinetic therapy to restore the gut's own bacterial clearance mechanism. Alongside this, we repair the intestinal lining that the bacteria damaged, restore the microbiome they displaced, and correct the nutritional deficiencies that accumulated during the malabsorption period. The result is not just a negative lab test. It is a gut that is genuinely less vulnerable to the same overgrowth establishing itself again.
SIBO AND THE REST OF THE BODY
The bacteria in the small intestine are not contained there. Their metabolic byproducts reach every tissue in the body through the bloodstream — driving inflammation, impairing repair, and producing symptoms that no one thinks to connect to a gut problem.
At True Health Centers, we routinely consider SIBO as a contributing factor in patients presenting with chronic musculoskeletal pain, fibromyalgia, treatment-resistant skin conditions, unexplained fatigue, and brain fog. When it is identified and treated, the systemic symptom improvement frequently surprises patients who came in for something they thought was entirely unrelated to their gut.
SIBO and chronic pain amplification
The lipopolysaccharides produced by SIBO bacteria are among the most potent triggers of systemic inflammation available. When they chronically enter the bloodstream through a permeable gut lining, they drive a persistent low-grade immune activation that sensitizes the central nervous system and amplifies pain signals from every source. Patients with chronic pain conditions that are not responding as expected to structural treatment frequently have SIBO as an invisible driver of their pain sensitivity and systemic inflammation.
SIBO and nutrient deficiencies affecting musculoskeletal recovery
The small intestine is where iron, B12, magnesium, zinc, and fat-soluble vitamins are absorbed. SIBO impairs absorption at all of these sites through both mechanical competition from the bacteria and through the damage to the intestinal lining they produce. Patients trying to recover from tendinopathy, stress fractures, or nerve injuries while carrying a SIBO-related nutrient malabsorption burden are attempting tissue repair without adequate building materials — and no amount of targeted supplementation will fully compensate while the absorptive environment remains compromised.
SIBO, motility, and the stress connection
The migrating motor complex that sweeps bacteria out of the small intestine between meals requires parasympathetic nervous system activation to function. Chronic stress and chronic sympathetic nervous system dominance directly impair this motility, predisposing to SIBO development and recurrence. This is one of the most important and least discussed connections in functional medicine: stress management is SIBO prevention. For patients with both chronic pain and SIBO, our constitutional hydrotherapy and autonomic regulation work is simultaneously treating both conditions by restoring the parasympathetic tone that pain resolution and bacterial clearance both depend on.
TAKE THE NEXT STEP
A comprehensive stool analysis can tell us in one appointment what years of standard GI workup has missed. Let us look.
SIBO testing, type-specific treatment, prokinetic recurrence prevention, and integrated whole-body care.
Not sure where to begin? Give us a call and we'll help you choose the best first step.